Covered recipient · General Payments record
GAIL KERR
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$211,032.31
- Reported across 309 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $35,253.00 | 11 |
| Food and Beverage | $2,077.73 | 24 |
| Travel and Lodging | $1,809.46 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $18,060.20 | 20 |
| Amgen Inc. | $5,360.89 | 4 |
| SOBI, INC | $3,172.26 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $2,970.87 | 2 |
| UCB, Inc. | $2,957.26 | 4 |
| E.R. Squibb & Sons, L.L.C. | $2,304.34 | 2 |
| Eli Lilly and Company | $2,147.86 | 2 |
| PFIZER INC. | $1,200.00 | 1 |
| Acerta Pharma LLC | $537.00 | 1 |
| Janssen Biotech, Inc. | $292.44 | 2 |
| Lilly USA, LLC | $113.97 | 2 |
| ABBVIE INC. | $23.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (44)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.10 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104054780 | CMS |
| Amgen Inc. | $3,000.00 | 02/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117596740 | CMS |
| Amgen Inc. | $2,200.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1111617499 | CMS |
| Amgen Inc. | $138.60 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111617495 | CMS |
| Amgen Inc. | $22.29 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111617497 | CMS |
| AstraZeneca Pharmaceuticals LP | $537.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105567959 | CMS |
| E.R. Squibb & Sons, L.L.C. | $64.34 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101727507 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,240.00 | 07/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101727445 | CMS |
| Eli Lilly and Company | $47.86 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134999096 | CMS |
| Eli Lilly and Company | $2,100.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134981690 | CMS |
| GENZYME CORPORATION | $238.68 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651543 | CMS |
| GENZYME CORPORATION | $289.88 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651545 | CMS |
| GENZYME CORPORATION | $166.03 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651547 | CMS |
| GENZYME CORPORATION | $100.00 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651549 | CMS |
| GENZYME CORPORATION | $56.90 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651551 | CMS |
| GENZYME CORPORATION | $54.55 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651553 | CMS |
| GENZYME CORPORATION | $59.11 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651555 | CMS |
| GENZYME CORPORATION | $10,812.00 | 04/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139651557 | CMS |
| GENZYME CORPORATION | $77.67 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651559 | CMS |
| GENZYME CORPORATION | $146.00 | 04/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651561 | CMS |
| GENZYME CORPORATION | $142.91 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651495 | CMS |
| GENZYME CORPORATION | $42.83 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651569 | CMS |
| GENZYME CORPORATION | $258.77 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651571 | CMS |
| GENZYME CORPORATION | $418.05 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651573 | CMS |
| GENZYME CORPORATION | $38.50 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651575 | CMS |
| GENZYME CORPORATION | $4,452.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139651577 | CMS |
| GENZYME CORPORATION | $356.89 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651579 | CMS |
| GENZYME CORPORATION | $175.88 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139651581 | CMS |
| GENZYME CORPORATION | $24.46 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651567 | CMS |
| GENZYME CORPORATION | $149.09 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139651565 | CMS |
| Janssen Biotech, Inc. | $150.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078389128 | CMS |
| Janssen Biotech, Inc. | $142.44 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078388864 | CMS |
| Lilly USA, LLC | $25.09 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134993352 | CMS |
| Lilly USA, LLC | $88.88 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134981692 | CMS |
| Novartis Pharmaceuticals Corporation | $95.87 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087040280 | CMS |
| Novartis Pharmaceuticals Corporation | $2,875.00 | 07/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1087040282 | CMS |
| PFIZER INC. | $1,200.00 | 03/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131585321 | CMS |
| SOBI, INC | $50.25 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141426297 | CMS |
| SOBI, INC | $125.01 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141426725 | CMS |
| SOBI, INC | $2,997.00 | 11/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141427923 | CMS |
| UCB, Inc. | $49.77 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143184970 | CMS |
| UCB, Inc. | $2,840.00 | 08/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143184975 | CMS |
| UCB, Inc. | $21.77 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143184979 | CMS |
| UCB, Inc. | $45.72 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143184983 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.